4.7 Article

The relation of depression with structural brain abnormalities and cognitive functioning: the Maastricht study

Journal

PSYCHOLOGICAL MEDICINE
Volume 52, Issue 15, Pages 3521-3530

Publisher

CAMBRIDGE UNIV PRESS
DOI: 10.1017/S0033291721000222

Keywords

Cerebral small vessel disease; cognitive functioning; depression; epidemiology; population-based study

Funding

  1. European Regional Development Fund via OP-Zuid
  2. Province of Limburg
  3. Dutch Ministry of Economic Affairs [31O.041]
  4. Stichting De Weijerhorst (Maastricht, the Netherlands)
  5. Pearl String Initiative Diabetes (Amsterdam, the Netherlands)
  6. CARIM School for Cardiovascular Diseases (Maastricht, the Netherlands)
  7. CAPHRI Care and Public Health Research Institute (Maastricht, the Netherlands)
  8. NUTRIM School for Nutrition and Translational Research in Metabolism (Maastricht, the Netherlands)
  9. Health Foundation Limburg (Maastricht, the Netherlands)
  10. Perimed
  11. Janssen-Cilag B.V. (Tilburg, the Netherlands)
  12. Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands)
  13. Sanofi Netherlands B.V. (Gouda, the Netherlands)

Ask authors/readers for more resources

Individuals with depression often experience cognitive deficits due to brain atrophy and cerebral small vessel disease. The study found associations between depression, impaired cognitive functioning, and presence of CSVD, especially in participants without type 2 diabetes, but CSVD did not mediate the association with cognitive impairment.
Background Individuals with depression often experience widespread and persistent cognitive deficits, which might be due to brain atrophy and cerebral small vessel disease (CSVD). We therefore studied the associations between depression, markers of brain atrophy and CSVD, and cognitive functioning. Methods We used cross-sectional data from the population-based Maastricht study (n = 4734; mean age 59.1 +/- 8.6 years, 50.2% women), which focuses on type 2 diabetes. A current episode of major depressive disorder (MDD, n = 151) was assessed by the Mini-International Neuropsychiatric Interview. Volumes of cerebral spinal fluid, white matter, gray matter and white matter hyperintensities, presence of lacunar infarcts and cerebral microbleeds, and total CSVD burden were assessed by 3 T magnetic resonance imaging. Multiple linear and logistic regression analyses tested the associations between MDD, brain markers and cognitive functioning in memory, information processing speed, and executive functioning & attention, and presence of cognitive impairment. Structural equation modeling was used to test mediation. Results In fully adjusted models, MDD was associated with lower scores in information processing speed [mean difference = -0.18(-0.28;-0.08)], executive functioning & attention [mean difference = -0.13(-0.25;-0.02)], and with higher odds of cognitive impairment [odds ratio (OR) = 1.60(1.06;2.40)]. MDD was associated with CSVD in participants without type 2 diabetes [OR = 1.65(1.06;2.56)], but CSVD or other markers of brain atrophy or CSVD did not mediate the association with cognitive functioning. Conclusions MDD is associated with more impaired information processing speed and executive functioning & attention, and overall cognitive impairment. Furthermore, MDD was associated with CSVD in participants without type 2 diabetes, but this association did not explain an impaired cognitive profile.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available